Clinical Trial

EARLY DIAGNOSIS OF SEPTIC DIC

Study acronym: EASY-DIC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Disseminated Intravascular Coagulation is a severe complication of septic shock, associated with high mortality, whose diagnosis relies on complex scores that are rarely used in practice. Preliminary studies have shown that increased neutrophil fluorescence is associated with Disseminated Intravascular Coagulation and could reflect NETosis, a key mechanism of immunothrombosis. This study aims to validate neutrophil fluorescence measured on the SthemA 801 analyzer, alone or integrated into an artificial intelligence model, as an early, reliable, and routinely usable biomarker for the diagnosis of septic Disseminated Intravascular Coagulation.
Trial Details
NCT Number NCT07630415
Lead Sponsor University Hospital, Strasbourg, France
Conditions Disseminated Intravascular Coagulation (DIC), Reanimation, Septic Shock
Enrollment 492 participants
Start Date 2026-06-15
Primary Completion 2028-12-15 (estimated)
Study Completion 2029-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-05